Want to see JP:5187 full AI Analyst Report?
5187 Stock Chart & Stats
¥1037.00
-¥1.00(-0.11%)
At close: 4:00 PM EST
¥1037.00
-¥1.00(-0.11%)
Day’s Range― - ―
52-Week Range¥973.00 - ¥1,244.00
Previous CloseN/A
Volume5.50K
Average Volume (3M)7.98K
Market Cap
¥10.40B
Enterprise Value¥5.00K
Total Cash (Recent Filing)¥5.43B
Total Debt (Recent Filing)¥749.70M
Price to Earnings (P/E)17.0
Beta0.29
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.18%
Share Statistics
EPS (TTM)78.19
Shares Outstanding9,664,327
10 Day Avg. Volume3,800
30 Day Avg. Volume7,980
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.53
Price to Sales (P/S)0.64
P/FCF Ratio88.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and growing equity provide durable financial flexibility: the company can fund working capital, absorb demand shocks, and invest in incremental capacity or product development without heavy reliance on volatile external financing. That structural strength supports resilience over the next 2–6 months.
Steady Revenue GrowthConsistent low-to-mid single-digit top-line growth reflects ongoing adoption and stable end-market demand for medical consumables. Durable recurring sales underpin predictable revenue trajectories, enabling multi-quarter planning for production, inventory and distribution investments despite modest growth rates.
Recurring Consumables Business ModelA disposables-focused model drives repeat purchases and sticky customer relationships in hospitals and clinics. This structural demand creates recurring revenue streams, supports steady utilization of manufacturing capacity, and reduces sensitivity to one-off sales, strengthening medium-term revenue visibility.
Bears Say
Inconsistent Cash GenerationSharp swing to weaker operating and free cash flow increases execution risk: it constrains funding for capex, working capital, and dividends, and may force reliance on external financing or asset sales. Persistent cash volatility undermines the company’s ability to consistently fund growth or absorb shocks over coming quarters.
Volatile ProfitabilityUneven net income and operating margins complicate forecasting and signal inconsistent cost control or one-off impacts. For a manufacturing/consumables firm, sustained margin volatility can weaken returns on invested capital and reduce the ability to scale sales profitably across product lines in the medium term.
Modest Growth & EPS ContractionLow single-digit revenue growth combined with a large negative EPS change signals constrained operating leverage and earnings pressure. Over several quarters this limits free cash expansion and reduces room for margin improvement or strategic investments, making it harder to materially boost scale or returns.
Create Medic Co., Ltd. News
5187 FAQ
What was Create Medic Co., Ltd.’s price range in the past 12 months?
Create Medic Co., Ltd. lowest stock price was ¥973.00 and its highest was ¥1244.00 in the past 12 months.
What is Create Medic Co., Ltd.’s market cap?
Create Medic Co., Ltd.’s market cap is ¥10.40B.
When is Create Medic Co., Ltd.’s upcoming earnings report date?
Create Medic Co., Ltd.’s upcoming earnings report date is Nov 04, 2026 which is in 81 days.
How were Create Medic Co., Ltd.’s earnings last quarter?
Create Medic Co., Ltd. released its earnings results on Aug 05, 2026. The company reported ¥13.23 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Create Medic Co., Ltd. overvalued?
According to Wall Street analysts Create Medic Co., Ltd.’s price is currently Overvalued.
Does Create Medic Co., Ltd. pay dividends?
Create Medic Co., Ltd. pays a Semiannually dividend of ¥27 which represents an annual dividend yield of 4.18%. See more information on Create Medic Co., Ltd. dividends here
What is Create Medic Co., Ltd.’s EPS estimate?
Create Medic Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Create Medic Co., Ltd. have?
Create Medic Co., Ltd. has 9,664,327 shares outstanding.
What happened to Create Medic Co., Ltd.’s price movement after its last earnings report?
Create Medic Co., Ltd. reported an EPS of ¥13.23 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.529%.
Which hedge fund is a major shareholder of Create Medic Co., Ltd.?
Currently, no hedge funds are holding shares in JP:5187
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Create Medic Co., Ltd.
Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman, suprapubic, and nephrostomy balloon catheters, as well as self-catheterization set, all silicone self-catheter for replacement, pure-cath, nephrostomy kit, cystostomy set, and all silicone malecot catheter; and gastroenterology products, such as all silicone ileus, stomach, and sengstaken blakemore tubes, as well as transanal ileus decompression tube set. It also provides PEG products comprising PEG kit pull-method, with loop fixture, and bumper type, as well as CLINY introducer PEG kit, loop fixture II, all silicone gastrostomy balloon catheter for replacement, balloon button set, facil button for replacement, gastrostomy replacement catheter set, all silicone PEG J catheter, and transgastric jejunal balloon tube and guidewire set; surgery products, which include PTC drainage tube, PTCD kit, cholangio-entero tube, and internal external drainage catheter for PTCD; all silicone endotracheal and tracheostomy tubes and micro catheter; and OEM products. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―